Sionna Therapeutics, Inc. · NASDAQ:SION
JPMorgan Chase & Co reported a 5.00% stake in Sionna Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 30, 2025
JPMorgan Chase & Co reported a 5.00% stake in Sionna Therapeutics, Inc., 2,221,188 shares, as a passive investor on Jun 30, 2025. Filed Jul 30, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 2,221,188
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.00% | 2,221,188 |
Source
Related
- Sionna Therapeutics, Inc.
- JPMorgan Chase & Co
- Sionna Therapeutics, Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 31, 2025
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · McKee Charlotte · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026